ID25704A - Barang manufaktur - Google Patents

Barang manufaktur

Info

Publication number
ID25704A
ID25704A IDP20000331D ID20000331D ID25704A ID 25704 A ID25704 A ID 25704A ID P20000331 D IDP20000331 D ID P20000331D ID 20000331 D ID20000331 D ID 20000331D ID 25704 A ID25704 A ID 25704A
Authority
ID
Indonesia
Prior art keywords
relates
present
manufacturing items
pharmaceutical
pde5
Prior art date
Application number
IDP20000331D
Other languages
English (en)
Indonesian (id)
Inventor
Jeffrey Thomas Emmick
K M Ferguson
W E Pullman
J S Whitaker
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22452153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID25704(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Publication of ID25704A publication Critical patent/ID25704A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Glass Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
IDP20000331D 1999-04-30 2000-04-26 Barang manufaktur ID25704A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13203699P 1999-04-30 1999-04-30

Publications (1)

Publication Number Publication Date
ID25704A true ID25704A (id) 2000-11-02

Family

ID=22452153

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000331D ID25704A (id) 1999-04-30 2000-04-26 Barang manufaktur

Country Status (47)

Country Link
EP (2) EP1415652A3 (de)
JP (2) JP4975214B2 (de)
KR (2) KR100577057B1 (de)
CN (2) CN1196487C (de)
AT (1) ATE251908T1 (de)
AU (3) AU3012900A (de)
BE (1) BE1012957A5 (de)
BR (2) BR0010181A (de)
CA (2) CA2307101C (de)
CH (2) CH692478A5 (de)
CO (1) CO5170493A1 (de)
CZ (1) CZ296534B6 (de)
DE (3) DE20007861U1 (de)
DK (2) DK200000677A (de)
DZ (1) DZ3171A1 (de)
EA (2) EA200000355A3 (de)
ES (2) ES2187234A1 (de)
FI (1) FI20000976A (de)
FR (1) FR2795646B1 (de)
GB (1) GB2351663A (de)
GR (1) GR1003575B (de)
HK (1) HK1041204B (de)
HR (2) HRP20000243A2 (de)
HU (2) HUP0001632A3 (de)
ID (1) ID25704A (de)
IE (1) IE20000315A1 (de)
IL (3) IL135817A0 (de)
IT (1) ITMI20000922A1 (de)
LT (1) LT4758B (de)
LU (1) LU90569B1 (de)
LV (1) LV12560B (de)
MX (2) MXPA00003997A (de)
NL (1) NL1015027C2 (de)
NO (2) NO20002097L (de)
NZ (2) NZ514882A (de)
PE (1) PE20010071A1 (de)
PL (2) PL339897A1 (de)
PT (2) PT102457A (de)
SE (1) SE0001518L (de)
SG (1) SG98384A1 (de)
SI (2) SI20361A (de)
SK (1) SK285415B6 (de)
SV (1) SV2002000055A (de)
TR (1) TR200001132A3 (de)
UA (1) UA72248C2 (de)
WO (1) WO2000066099A2 (de)
ZA (2) ZA200002058B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2435816T3 (es) * 1999-08-03 2013-12-23 Icos Corporation Formulación farmacéutica que comprende una Beta-carbolina y su uso para el tratamiento de la disfunción sexual
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
US20030153575A1 (en) * 2000-06-08 2003-08-14 Orme Mark W. Tetracyclic diketopiperazine compounds as pdev inhibitors
JP4220775B2 (ja) * 2000-08-02 2009-02-04 リリー アイコス リミテッド ライアビリティ カンパニー ホスホジエステラーゼ阻害剤としての融合複素環式誘導体
JP4216709B2 (ja) * 2001-06-05 2009-01-28 リリー アイコス リミテッド ライアビリティ カンパニー Ｐｄｅ５阻害剤としてのテトラ環状化合物
GB0129274D0 (en) * 2001-12-06 2002-01-23 Pfizer Ltd Novel kit
US20060205733A1 (en) * 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
JP5823093B2 (ja) 2006-03-28 2015-11-25 ジャヴェリン ファーマシューティカルズ インコーポレイテッド 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物
US7495024B2 (en) 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
DE102007028869A1 (de) 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
WO2012107541A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
EP2672959A1 (de) 2011-02-10 2013-12-18 Synthon BV Granulierte zusammensetzung mit tadalafil und einem sprengmittel
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
KR20150056443A (ko) 2013-11-15 2015-05-26 한미약품 주식회사 타다라필 및 암로디핀을 포함하는 복합제제
KR102646431B1 (ko) 2017-09-29 2024-03-12 한미약품 주식회사 생산성 및 균일성이 개선된 타다라필을 함유하는 고형제제 및 그 제조방법
US20210137919A1 (en) * 2018-02-07 2021-05-13 Smawa Gmbh Pharmaceutical formulations, method for producing a pharmaceutical formulation, and medicament comprising same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9401090D0 (en) * 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9511220D0 (en) * 1995-06-02 1995-07-26 Glaxo Group Ltd Solid dispersions
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
YU49898A (sh) 1996-05-10 2000-03-21 Icos Corporation Hemijska jedinjenja
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
WO1999059584A1 (en) * 1998-05-20 1999-11-25 Schering Corporation Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
AU1025899A (en) 1998-09-16 2000-04-03 Icos Corporation Carboline derivatives as cgmp phosphodiesterase inhibitors
EP1120120A4 (de) * 1998-10-05 2009-04-29 Eisai R&D Man Co Ltd Tableten die sich unmittelbar in der mundhöhle auflösen
WO2000053148A2 (en) * 1999-03-08 2000-09-14 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
EP1173167A4 (de) * 1999-04-30 2004-07-14 Lilly Icos Llc Behandlung der störungen der weiblichen erregbarkeit
US6451807B1 (en) * 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor

Also Published As

Publication number Publication date
CA2371684C (en) 2007-10-23
EA005416B1 (ru) 2005-02-24
HU0001632D0 (en) 2000-06-28
KR20020008396A (ko) 2002-01-30
SG98384A1 (en) 2003-09-19
EP1173181A2 (de) 2002-01-23
FR2795646A1 (fr) 2001-01-05
IL146098A0 (en) 2002-07-25
ZA200108900B (en) 2003-03-26
JP2000336043A (ja) 2000-12-05
HUP0200912A3 (en) 2003-07-28
HK1041204B (zh) 2004-03-05
ES2187234A1 (es) 2003-05-16
ITMI20000922A1 (it) 2001-10-26
KR20010020779A (ko) 2001-03-15
EA200000355A3 (ru) 2001-02-26
FI20000976A (fi) 2000-10-30
HRP20010778B1 (en) 2005-04-30
NZ504163A (en) 2001-11-30
UA72248C2 (en) 2005-02-15
HUP0200912A2 (en) 2002-08-28
SE0001518D0 (sv) 2000-04-26
IL146098A (en) 2007-06-03
DE60005940T2 (de) 2004-07-29
EP1173181B1 (de) 2003-10-15
LT2000035A (en) 2000-11-27
DK1173181T6 (en) 2015-04-27
SI1173181T1 (en) 2004-04-30
CA2371684A1 (en) 2000-11-09
ATE251908T1 (de) 2003-11-15
TR200001132A2 (tr) 2001-01-22
IL135817A0 (en) 2001-05-20
PT1173181E (pt) 2004-02-27
SV2002000055A (es) 2002-07-03
KR100577057B1 (ko) 2006-05-10
SI20361A (sl) 2001-04-30
NO20015275L (no) 2001-12-06
CZ20013879A3 (cs) 2002-04-17
LV12560B (en) 2001-04-20
ES2208317T7 (es) 2015-09-15
PL352629A1 (en) 2003-08-25
EP1415652A3 (de) 2004-05-12
CH1173181H1 (de) 2019-07-15
CZ296534B6 (cs) 2006-04-12
CH692478A5 (de) 2002-07-15
MXPA00003997A (es) 2002-03-08
CA2307101C (en) 2003-01-28
AU2004201988A1 (en) 2004-06-10
BR0003046A (pt) 2002-07-23
WO2000066099A2 (en) 2000-11-09
NO20002097L (no) 2001-10-26
PL197813B1 (pl) 2008-04-30
CN1384746A (zh) 2002-12-11
EP1415652A2 (de) 2004-05-06
DK1173181T3 (da) 2004-02-16
HUP0001632A2 (hu) 2001-05-28
FR2795646B1 (fr) 2002-08-16
DK200000677A (da) 2000-10-31
NO20015275D0 (no) 2001-10-29
SE0001518L (sv) 2000-10-31
HUP0001632A3 (en) 2001-12-28
GB2351663A (en) 2001-01-10
NO322013B3 (no) 2017-11-06
NL1015027A1 (nl) 2000-10-31
ZA200002058B (en) 2000-11-02
CN1196487C (zh) 2005-04-13
DE10021266A1 (de) 2000-11-16
NO322013B1 (no) 2006-08-07
JP4975214B2 (ja) 2012-07-11
DZ3171A1 (de) 2000-11-09
PE20010071A1 (es) 2001-03-22
HRP20000243A2 (en) 2001-12-31
ES2208317T3 (es) 2004-06-16
IE20000315A1 (en) 2001-03-07
GR20000100153A (el) 2000-12-29
NL1015027C2 (nl) 2001-02-14
AU769946C (en) 2005-01-13
NZ514882A (en) 2003-08-29
ITMI20000922A0 (it) 2000-04-26
EA200101008A1 (ru) 2002-04-25
GR1003575B (el) 2001-05-14
LU90569B1 (fr) 2002-02-27
NO20002097D0 (no) 2000-04-25
PT102457A (pt) 2000-11-30
BR0010181A (pt) 2003-02-25
LT4758B (lt) 2001-02-26
SK285415B6 (sk) 2007-01-04
JP2002543116A (ja) 2002-12-17
PL339897A1 (en) 2000-11-06
LV12560A (en) 2000-11-20
BE1012957A5 (fr) 2001-06-05
FI20000976A0 (fi) 2000-04-26
HK1041204A1 (en) 2002-07-05
HRP20010778A2 (en) 2002-12-31
CO5170493A1 (es) 2002-06-27
DE20007861U1 (de) 2000-08-24
AU4490800A (en) 2000-11-17
EA200000355A2 (ru) 2000-10-30
GB0010199D0 (en) 2000-06-14
SK15632001A3 (sk) 2002-02-05
WO2000066099A3 (en) 2001-01-18
CA2307101A1 (en) 2000-10-30
DE60005940T3 (de) 2015-08-27
HU0200912D0 (en) 2002-04-29
HU230369B1 (hu) 2016-03-29
CN1292264A (zh) 2001-04-25
AU769946B2 (en) 2004-02-12
EP1173181B3 (de) 2015-03-25
AU3012900A (en) 2000-11-02
MXPA01010837A (es) 2002-11-07
DE60005940D1 (de) 2003-11-20
TR200001132A3 (tr) 2001-01-22

Similar Documents

Publication Publication Date Title
ID25704A (id) Barang manufaktur
WO2001080860A3 (en) Daily treatment for erectile dysfunction using a pde5 inhibitor
GEP20094596B (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction